FIELD: medicine.
SUBSTANCE: invention relates to medicine, ophthalmology, and can be used for treating hemophthalmia. For this purpose vitreous body is subjected to laser impact and trombovasim is introduced. Trombovasim is introduced perorally for 5 days before laser treatment and its introduction continues during sessions of vitreous body exposure to laser impact with general term up to 10 days. Laser impact is performed by coagulating laser with wavelength 488-532 nm. Laser beam is directed into vitreous body by means of three-mirror Goldman lens.
EFFECT: method makes it possible to increase efficiency of treating hemophthalmia of various prescription.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING FIBRINOID SYNDROME AFTER CATARACT EXTRACTION WITH IMPLANTATION OF INTRAOCULAR LENS | 2009 |
|
RU2414194C1 |
METHOD OF TREATING PREMACULAR HEMORRHAGES | 2012 |
|
RU2495653C1 |
METHOD FOR TREATING THE CASES OF HEMOPHTHALMIA | 2000 |
|
RU2180204C2 |
METHOD FOR TREATING PRERETINAL HEMORRHAGE CASES | 2004 |
|
RU2278646C1 |
METHOD OF WIDE - SPREAD HEMOPHTHALMIA AND TOTAL HEMOPHTHALMIA TREATMENT IN PATIENTS WITH DIABETIC RETINOPATHY | 2008 |
|
RU2391954C2 |
METHOD FOR PREVENTING RETINAL TRACTION DETACHMENT AND NEOVASCULARIZATION AT OPHTHALMIC DISEASES | 2001 |
|
RU2186552C1 |
METHOD OF PREVENTING AND TREATING RETINOPATHY OF PREMATURITY | 2015 |
|
RU2596721C1 |
METHOD FOR COMBINED LASER TREATMENT OF VALVE RETINAL RUPTURES WITH VITREORETINAL ADHESION ON ENTIRE AREA OF RETINAL VALVE | 2016 |
|
RU2625778C1 |
METHOD OF TREATING PERIPHERAL TRACTION RETINAL DETACHMENT IN DIABETIC RETINOPATHY | 2019 |
|
RU2739698C1 |
METHOD OF TREATING CYSTOID MACULAR EDEMA INDUCED BY VITREORETINAL TRACTIONS | 2008 |
|
RU2376000C1 |
Authors
Dates
2011-06-27—Published
2009-12-03—Filed